Dr. Chris Airress

Dr. Chris Airress, CEO of CorTechs Labs, has remained a central member of the leadership team for over 12 years and provided a significant catalyst to the development of the flagship product, NeuroQuant. He has served as the company’s CTO and COO in previous roles at the company. Before joining CorTechs Labs, he oversaw the development and growth of therapeutic drugs designed to combat metastatic melanoma as the chief development officer for California Stem Cell.